Latar belakang: Peningkatan jumlah sindrom metabolik (MetS) (OR 12, 13; 95% CI 2,46; p = 0,001), tekanan darah tinggi (OR 9, 33; 95% CI 2, (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) 56; p = 0,001), HDL rendah (OR 8, 33; 95% CI 2, (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) 05; p = 0,003), and glukosa puasa terganggu (p = 0,03) 
Metabolic syndrome (MetS) is a constellation of all metabolic risk factors comprised of: 1) atherogenic dyslipidemia (high serum triglycerides, Apolipoprotein-B, low-density lipoprotein/LDL, and low high-density lipoprotein/HDL); 2) elevated blood pressure; 3) elevated glucose associated with insulin resistance; 4) pro-thrombotic state; and 5) pro-inflammatory state. 1 There are a lot of criteria for diagnosing MetS. In our research, we employed definition from International Diabetes Federation (IDF), which consists of central obesity, impaired fasting glucose, hypertriglyceridemia, low HDL, and hypertension.
The MetS may increase pro-inflammatory adipocyte products such as non-esterified fatty acids (NEFAs), inflammatory cytokines, and plasminogen-activator inhibitor-1 (PAI-1). Moreover, it may decrease the anti-inflammatory products: adiponectin, leptin, and resistin. The excess of NEFAs generates insulin resistance of the muscle and liver cells and atheroma production by increasing synthesis of triglycerides and forming fatty liver. Inflammatory cytokines alter the insulin secretion signal in pancreas and augment atherogenic macrophage. PAI-1 contributes to pro-thrombotic state of the vascular system. The reduced adiponectin will tip the balance further into the pro-inflammatory state. In consequence, the cardiovascular system will become more vulnerable to coronary heart disease, stroke, thrombosis, lung emboli, and others. 2, 3 There are many tools that may help assessing coronary heart diseases (CHD) risks, such as Framingham, 4 JBS, 5 ASSIGN, 6 and QRISK. 7 Those tools were studied in limited population (one country) 8 which is a reason why Framingham equations predict the degree of risk less well in men and women younger than age 30, Japanese-American men, Hispanic men and NativeAmerican women. 9 Framingham risk score (FRS) describes 10 year-CHD risks with several criteria of MetS included, such as: total cholesterol, systolic and diastolic blood pressure, and sex (for age). 4 FRS has been proven helpful to predict the occurrence of primary coronary heart disease (CHD) with sensitivity and specificity of 56.5% and 75%, respectively.
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Moreover, it is used to calculate absolute risk of CHD in patients without previous history of CHD, stroke, and peripheral vascular disease. 9 Obesity is a state of excess body fat. Measurement of obesity can be done in several ways. Two wellaccepted methods in general practice are BMI (kg/m 2 ) and waist circumference. Cut-off points for BMI and waist circumference are very much dependent on particular population. In this research we use Asian population classification for obesity and abdominal obesity. 11 It is ironic that substantial expansion of technology has fashioned a lot of people to become more sedentary. Sedentary lifestyle is directly related to the occurrence of obesity. In Asia-Pacific regions, the prevalence of obesity in young adults (18-40 years old) increases by 2% per year. 11, 12 Researches from various centers also show the growing trend of CHD in young adults who are supposed to be in active age. 12 Together with other emerging risk factors (dyslipidemia, hyperglycemia, hypertension, endothelial dysfunction, and insulin resistance), obesity play a great role in development of various metabolic and CHD including MetS. 13 Obesity with fat excess also causes insulin resistance. On the other hand, insulin resistance worsens the adverse effects caused by obesity. This vicious cycle in turn will increase the risk for CHD. 2 The substantial increase in the prevalence of the MetS in healthy young adults is driven mostly by the increase in obesity. 14 Weiss et al 15 also stated that the prevalence has become a burden among obese subjects and increased with worsening obesity. Biomarkers for risk of CHD have already been present even in young age. Many reports also point out that the presence of MetS contributes to the increased risk for CHD and type-2 diabetes. MetS will amplify the risk of CHD by two-fold and the risk of diabetes by five-fold. 16, 17 Moreover, diabetes will enhance the risk of CHD by three-fold and once a person conflicted both diseases, the prognosis will be significantly reduced. Therefore it is very important that prediction, or even diagnosis, of MetS and FRS in obese young adults be made as soon as possible to allow specific prevention and/or management according to risk factors. Our objectives were to identify the prevalence of MetS, FRS, and to know the relationship between them in obese young adults. We hope that this study could be regarded as a stepping stone for making public health policy. The subjects were selected consecutively.
METHODS
At the first meeting, we measured weight, height, waist circumference, and blood pressure with appropriate measurement methods ( Table 1 ). All subjects that fit in the inclusion criteria were included. Those who matched one or more exclusion criteria (having a fever, in pregnancy, and/or suffering from malignancy) were excluded. They also filled some questionnaires for FRS data.
Calculation of FRS was done from NCEP-ATP III.
4 FRS were calculated based on age, gender, total cholesterol, HDL-cholesterol, smoker, and systolic blood pressure or currently on any medication to treat high blood pressure. It classified the age from 20 to 34 years-old groups. In our study for FRS calculation, subjects who were less than 20 years old were considered as 20 years of age. We did a one-month recall of smoking. The subjects were considered as smokers if at least they smoked three cigarettes a week.
We recruited 80 subjects of which 70 subjects were examined. The subjects were then asked to fast about 14 to 16 hours. After that, blood samples were drawn and checked for fasting blood glucose, total cholesterol, high-density lipoprotein, and triglyceride blood level in Department of Clinical Pathology Cipto Mangunkusumo Hospital (RSCM).
The MetS was diagnosed with the criteria from IDF. They are central obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm for women) plus two/more other clinical findings: 1) Fasting blood glucose ≥ 100 mg/dL or consuming glucose-lowering drugs; 2) triglyceride level in blood ≥ 150 mg/dL or consuming triglyceridelowering drugs; 3) HDL < 40 mg/dL for men and < 50 mg/dL for women; and 4) systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or consuming blood pressure-lowering drugs. 19 All subjects signed informed consent and this protocol was approved by the Ethic Committee from Faculty of Medicine Universitas Indonesia. The collected or processed data were kept confidential.
Descriptive data were showed in frequencies; means and standard deviations for data with normal distribution; median, minimum, and maximum if data were not normally distributed. In the analysis, odds ratios were calculated between MetS components with MetS and FRS category. We categorized FRS into < 1% and ≥ 1% and only subjects that has abdominal obesity were included in the MetS components and FRS category analysis. Then, chi-square analysis, with Fisher as the alternative, was used to examine the association for categorical variables. Data were analyzed with SPSS® for Windows version 17.
RESULTS
A total of 70 subjects attended the examination process in Clinical Pathology RSCM Laboratory. Fifty one of the participants (72.9%) were male. None of the subjects had Body height Body height was measured using microtoise with 0.1 cm precision; the subjects stand erect on flat floor without any footwear or headgear, toe-to-toe, heels and spine are right next to the wall.
Waist circumference
Waist circumference was measured using measuring tape with 0.1 cm precision; the measuring tape is wrapped on the pelvic bone/iliac crest parallel to the floor regardless of the navel location at the time of normal expiration.
Blood pressure
Blood pressure was measured using mercury sphygmomanometer with 1 mmHg precision and a binaural stethoscope; the measurements take place on the resting subjects' brachial artery using Korotkoff method, which measure systole in Korotkoff sound I and diastole in Korotkoff sound V. 20 and IDF. 19 Moreover, comparing prevalence MetS in obese people is also problematical due to difference of the BMI cut-off for obesity among ethnics. In Asia-Pacific regions the cutoff was 25 kg/m 2 , but in Western population the cut-off was 30 kg/m 2 .
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Using IDF criteria, our study found prevalence of MetS was 18.6% in obese young adults. In Finland 21 and US 19 which apply IDF criteria, the prevalence was 55.4% and 65.1% in obese adults, respectively. Other studies reported prevalence of MetS using ATP III criteria was 56.1-64.2% among obese US adults. 19, 22 In Asia, there are no specific data that explicitly show prevalence of MetS in obese adults. According to Nestel et al 23 and Mohamud et al, 24 the prevalence of MetS using IDF criteria in Asian adults was 9.6-26.3%. In Jakarta, 2006, the prevalence of this disorder with ATP III-modified Asian criteria was 28.4% in adults. 25 The prevalence is seen greater in Western countries. It may be affected by the higher cut-off BMI to bring in obese group. Greater BMI may give rise to number of MetS. Pan et al showed the evidence in all races that the higher BMI the subjects had, the more prevalence of MetS would be found. 26 Beside BMI, older age also increases the prevalence of MetS. The higher the age of the population, the higher the prevalence will be. 19, 24 But, Ford 19 showed that the trend was only significant till 70 year-old population; after that age population, the prevalence did not remain higher. Compared to the prevalence of MetS in Bogor 27 among obese adults (31-55 years old) which was 36.2%, our result showed lesser prevalence because our age group was lower. Conversely, compared to Jamaican 28 youths (18-20 years), of which prevalence was only 1.2% (BMI = 23.08 ± 5.09 kg/m 2 ), our result was much higher because of higher age group and BMI (Table 2) in our study.
Our prevalence data was more similar with studies conducted to children and adolescent age group in Spain (18.5%), Brazil (17.4%), Italy (13.9%), and France (10.9%). China, in which people closely related with Indonesian, had the lowest prevalence of MetS (10.3%) among obese children. 29 The prevalence of young adults was similar with children and adolescents, because the age group followed right after adolescents.
In children and adolescents, the prevalence of MetS also depends on BMI. Wickham et al 30 showed the prevalence of the disorder was 30.3% in obese adolescents with a BMI mean of 38.2 ± 8.5 kg/m 2 . Thus, to compare the prevalence of MetS, we need to consider the BMI and age groups. The higher the age group and/or BMI, the higher the prevalence will be.
Our study showed obese young adults who had hypertriglyceridemia or high blood pressure or low-HDL had 8-12 times higher risks of metabolic syndrome. It was thought due to the obesity-related insulin sensitivity impairment and was correlated with the degree of overweight. 31 Ferrannini et al 32 supported the data that obesity was significantly associated with reduction of insulin sensitivity.
In our study, FRS was found relatively low. From 70 obese young adults, only 6% of subjects had FRS ≥ 1% and the highest risk was 4%. All were below 10% risk, categorized as low risk. 33 The result was not different with Berry et al 34 who found the risk < 1% to 4% in 5154 subjects of 18-29 years old population of which 51.4% of the subjects were obese. They did a cohort study and found 10-years-coronary heart disease mortality rate was 0.58%. FRS is heavily dependent on age. This dependence can be understood by looking at the score for age in group 20-34 years of age where they give a score of -7 and -9 for women and men, respectively. Consequently, it needs severe abnormality (total cholesterol, HDL, systolic blood pressure) to affect the score. This results in FRS tendency to underestimate cardiovascular events in young adults. 35 Moreover, Lee et al 36 in their retrospective study showed that sensitivity of FRS in identifying at least intermediate risk (10-years risk of cardiovascular events ≥ 10%) was 37.0% in young patients (< 40 years old).
Obese young adults who had hypertriglyceridemia were twelve times more likely to have higher FRS (OR 12.25; 95%CI 0.99-151.36; p = 0.069), although it might not be significant because of limited subjects. This is supported by a study that showed elevated moderate hypertriglyceridemia and waist circumference in asymptomatic men increases the risk for CHD, although elevated cholesterol, elevated LDL-cholesterol and other traditional risk factors were absent. 37 As hypertriglyceridemia was indirectly related with obesity (BMI), we propose that BMI would also associate with FRS. Ghandehari et al 38 reported that FRS was significantly associated with BMI and abdominal obesity (waist circumference).
Our data showed that MetS was not associated with higher FRS (p = 0.154). We considered it was because of our in-adequate sample size and number of events. However, till now, there are still limited researches that relate MetS with FRS. Many of them compare each other to propose better cardiovascular prediction.
MetS increased the risk for CHD significantly. 20, 26 Higher FRS was also shown to have higher hazard ratio for CHD.
10,39 Although we did not find association between MetS and high FRS in obese people, we suggest that patients should be assessed with MetS and FRS in order to exclude the risks. Both might not relate to each other but they have been shown to be significant tools for CHD with their own disadvantages and advantages. 10, 40 Moreover, when used together, McNeill found that they would enhance the predictive value. 41 We found 100% subjects had < 10% risk in obese subjects with MetS. It was similar with study conducted in North-India, Bansal et al 35 that found 95.9% subjects had < 10% risk in ≤ 38 years old population. However, this data should not be interpreted that obese people who had MetS were harmless. FRS only predicts short term risk reduction (≤ 10 years) whereas MetS is aimed at long-risk reduction mainly through lifestyle modification.
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With this data, we want to encourage people, particularly obese young adults, to change lifestyle immediately. Reinehr et al 31 showed improvement of cardiovascular risk factors every BMI reduction in obese children and adolescents. This supported the view of intervening obesity as early as possible.
Because older age and higher BMI will bring increased risks not only in MetS but also FRS, we propose that intervention should be done as early as possible to avoid CHD using MetS and FRS. Insulin resistance becomes important link between MetS and FRS with obesity (BMI). Insulin resistance-related complications such as hypertriglyceridemia had been a high risk factor in our study for both MetS and FRS. The model of this proposal is showed in figure 1 . Several limitations of our study need to be considered. The cross-sectional and consecutive research limited us to assess the real mortality CHD event rate that should be examined with prospective cohort study. Moreover, the subjects and event groups of MetS and FRS were limited, so that we could not directly associate the age. The other drawback was insulin resistance was not checked, even though it is the important link between obesity with FRS and MetS. But, the strong point of our study is that it was done in obese young adults which was not commonly documented previously. Furthermore, young adults could have better results if intervention was done earlier.
Obese
In conclusion, prevalence of MetS in obese young adult was similar with prevalence of the disorder in obese children and adolescents because it was highly dependent on age. Hypertriglyceridemia had been prone to be high risk factor in our study for both MetS and FRS. It might be because hypertriglyceridemia is an insulin resistance-related complication which becomes important link between MetS and FRS with obesity (BMI).
In conclusion, although we found MetS and FRS were not associated with each other, MetS and FRS as significant predictors for CHD should not be used separately. Both predictors have their own strengths and weaknesses when used individually, hence it would be better for every patient to be taken with both approaches in assessing their CHD risks.
